SIAG
TCRT icon

Safeguard Investment Advisory Group’s Alaunos Therapeutics TCRT Stock Holding History

Safeguard Investment Advisory Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-34
Closed -$12K – 638
2020
Q4 		$12K Buy
+34
New +$13.5K 0.01% 382

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Safeguard Investment Advisory Group's TCRT Position: Q1 2021 in Review

Safeguard Investment Advisory Group sold out of Alaunos Therapeutics (TCRT) in Q1 2021, closing a stake of 34 shares — an estimated $12K sold.

Safeguard Investment Advisory Group first reported a position in TCRT in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 151 funds tracked by Wall St. Rank hold TCRT as of Q1 2021.

  • Safeguard Investment Advisory Group reported no remaining Alaunos Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Safeguard Investment Advisory Group sold 34 Alaunos Therapeutics shares in Q1 2021, an estimated $12K.
  • Safeguard Investment Advisory Group first reported a position in Alaunos Therapeutics in Q4 2020 and held it in 1 quarter.
  • Safeguard Investment Advisory Group's Alaunos Therapeutics position peaked at $12K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2021.

Based on Safeguard Investment Advisory Group's 13F filing for Q1 2021, filed 10 May 2021.